Cargando…
Losartan-induced Pancreatitis
Drug-induced acute pancreatitis (DIAP) is a rare gastrointestinal condition but well-known in the medical literature. The medications have been classified into four subgroups (Classes I-IV) depending upon the propensity of the cases discussed in the literature, interval time period between drug init...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937474/ https://www.ncbi.nlm.nih.gov/pubmed/31893179 http://dx.doi.org/10.7759/cureus.6253 |
_version_ | 1783483884375113728 |
---|---|
author | Anwar, Shamsuddin M Aqsa, Anum Shaukat, Rameez |
author_facet | Anwar, Shamsuddin M Aqsa, Anum Shaukat, Rameez |
author_sort | Anwar, Shamsuddin M |
collection | PubMed |
description | Drug-induced acute pancreatitis (DIAP) is a rare gastrointestinal condition but well-known in the medical literature. The medications have been classified into four subgroups (Classes I-IV) depending upon the propensity of the cases discussed in the literature, interval time period between drug initiation to pancreatitis, and reaction to the drug with reintroduction. Our clinical case is one such example where losartan was described as the agent of recurrent pancreatitis after excluding all other possible causes with laboratory and imaging studies. |
format | Online Article Text |
id | pubmed-6937474 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-69374742019-12-31 Losartan-induced Pancreatitis Anwar, Shamsuddin M Aqsa, Anum Shaukat, Rameez Cureus Gastroenterology Drug-induced acute pancreatitis (DIAP) is a rare gastrointestinal condition but well-known in the medical literature. The medications have been classified into four subgroups (Classes I-IV) depending upon the propensity of the cases discussed in the literature, interval time period between drug initiation to pancreatitis, and reaction to the drug with reintroduction. Our clinical case is one such example where losartan was described as the agent of recurrent pancreatitis after excluding all other possible causes with laboratory and imaging studies. Cureus 2019-11-28 /pmc/articles/PMC6937474/ /pubmed/31893179 http://dx.doi.org/10.7759/cureus.6253 Text en Copyright © 2019, Anwar et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Gastroenterology Anwar, Shamsuddin M Aqsa, Anum Shaukat, Rameez Losartan-induced Pancreatitis |
title | Losartan-induced Pancreatitis |
title_full | Losartan-induced Pancreatitis |
title_fullStr | Losartan-induced Pancreatitis |
title_full_unstemmed | Losartan-induced Pancreatitis |
title_short | Losartan-induced Pancreatitis |
title_sort | losartan-induced pancreatitis |
topic | Gastroenterology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937474/ https://www.ncbi.nlm.nih.gov/pubmed/31893179 http://dx.doi.org/10.7759/cureus.6253 |
work_keys_str_mv | AT anwarshamsuddinm losartaninducedpancreatitis AT aqsaanum losartaninducedpancreatitis AT shaukatrameez losartaninducedpancreatitis |